Versuchen GOLD - Frei
Treatment that is tailored just for you
Financial Express Mumbai
|June 22, 2025
Can personalised medicine and gene editing be the future of healthcare? Experts weigh in on the medical model that helps identify the root cause of an illness at a molecular level
A NEW STUDY, published in The New England Journal of Medicine in May this year, brought to light a unique case involving a 7-month-old baby, known as 'KJ', who was born with a life-threatening liver disorder known as carbamoyl phosphate synthetase 1 (CPS1) deficiency.
In the case, reported in February this year, it was for the first time that a gene-editing CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based technology was used with a specific mutation in a living person. While the baby wasn't fully cured, the treatment - a historic step towards personalised medicine - was initiated to ensure that any risks associated with the condition are minimised.
Explaining what personalised medicine is, Dr Shrinidhi Nathany, consultant, molecular haematology and oncology, Fortis Memorial Research Institute, Gurugram, explains, "Personalised medicine refers to a transformative approach in healthcare that uses an individual's genetic, molecular, and clinical profile to guide diagnosis and treatment."
Dr Mandeep Singh Malhotra, director of surgical oncology at the CK Birla Hospital, Delhi, explains, "Instead of using a one-size-fits-all method, personalised medicine involves evaluating the patient's DNA and RNA to detect any aberrations in the genome that may be causing the disease. This helps in identifying the root cause of an illness, whether it's a rare genetic disorder, cancer, or another condition, at a molecular level."
The specific treatment method used in this case was gene-editing. Dr Sajjan Rajpurohit, senior director of medical oncology at BLK-Max Super Speciality Hospital, says, "Gene editing refers to a set of technologies that allow scientists to modify an organism's DNA. One of the most well-known gene-editing techniques is CRISPR-Cas9, which enables precise alterations to specific genes. This technology has opened new avenues for treating genetic disorders" by correcting mutations at their source."
Diese Geschichte stammt aus der June 22, 2025-Ausgabe von Financial Express Mumbai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Financial Express Mumbai
Financial Express Mumbai
IAF’s new ‘Sindoor’ formation on R-Day
FIGHTER JETS OF the Indian Air Force will fly in a special Sindoor formation at the Republic Day flypast this year, in a significant display of India’s air power.
1 min
January 23, 2026
Financial Express Mumbai
Bangladesh defiant: Will play, not in India
AFTER ICC ULTIMATUM ON WORLD CUP PARTICIPATION
2 mins
January 23, 2026
Financial Express Mumbai
IndiGo Q3 profit falls 78% on Dec trouble
INTERGLOBE AVIATION, WHICH operates IndiGo, on Thursday reported a sharp fall in its October-December profit after onetime charges linked to widespread flight disruptions in December dragged earnings well below market expectations, even as revenue grew at a modest pace.
2 mins
January 23, 2026
Financial Express Mumbai
India’s coal revival looks impossible to achieve
ON the planet, the great surge of coal power that fuelled two centuries of industrialisation is receding.
3 mins
January 23, 2026
Financial Express Mumbai
Air India loss in FY26 may cross ₹15,000 cr
AIR INDIA IS set to report a record annual loss after last year’s deadly crash and airspace shutdowns wiped out progress towards a turn around, according to people familiar with the matter.
1 mins
January 23, 2026
Financial Express Mumbai
How the new GDP series could alter growth figures
NATIONAL STATISTICAL OFFICE (NSO) released the advance estimates for 2025-26, indicating annual GDP growth of 7.4%, with a decadal growth of 5.9% (2015-2026).
2 mins
January 23, 2026
Financial Express Mumbai
Top Maoist with ₹1-crore bounty among 15 killed in Jharkhand
A TOP LEADER of the banned Communist Party of India (Maoist), carrying a Rs 1-crore bounty on his head, was among 15 Maoists killed on Thursday in an encounter with security forces in the Saranda forest area near Chaibasa in Jharkhand’s West Singhbhum district, officials said.
1 mins
January 23, 2026
Financial Express Mumbai
Brokerages flag margin risks post Eternal Q3 show
BROKERAGES OFFERED A mixed assessment of Eternal’s December-quarter performance, flagging near-term margin risks despite stronger-than-expected growth and profitability, as competitive intensity in quick commerce and food delivery continues to rise.
1 mins
January 23, 2026
Financial Express Mumbai
Nov deadline for DPDP compliance
Centre may trim timeline by 6 mths
2 mins
January 23, 2026
Financial Express Mumbai
Ujjivan SFB profit up 71% to ₹186 crore
Bank on Thursday reported a 71% growth in its net profit to %186 crore for the third quarter ended December 31.The bank reported an all-time high net interest income (NII) of $1,000 crore, up 12.8%.
1 min
January 23, 2026
Listen
Translate
Change font size

